Reply to: Probiotics for the Prevention of COVID-19 Sequelae
- PMID: 35999061
- PMCID: PMC9376338
- DOI: 10.1016/j.arcmed.2022.08.005
Reply to: Probiotics for the Prevention of COVID-19 Sequelae
Conflict of interest statement
Conflict of Interest None.
Comment on
-
Probiotics in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects.Arch Med Res. 2021 Aug;52(6):582-594. doi: 10.1016/j.arcmed.2021.03.002. Epub 2021 Mar 19. Arch Med Res. 2021. PMID: 33785208 Free PMC article. Review.
-
Probiotics for the Prevention of COVID-19 Sequelae.Arch Med Res. 2022 Sep;53(6):643. doi: 10.1016/j.arcmed.2022.08.004. Epub 2022 Aug 25. Arch Med Res. 2022. PMID: 36030115 Free PMC article. No abstract available.
References
-
- De Almeida VM, Engel DF, Ricci MF, et al. Gut microbiota from patients with mild COVID-19 cause alterations in mice that resemble post-COVID syndrome. Preprint. ResearchSquare. 2022 rs.3.rs-1756189.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
